Depression and Anxiety Trial, Recruiting (NCT05921773)

Depression and Anxiety Trial, Recruiting NCT05921773 Sponsor: National Taiwan University Hospital Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT05921773 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with Generalized Anxiety Disorder (GAD) by a psychiatrist using standard diagnostic guidelines (DSM-V).
People whose first language is Chinese.
People who are right-handed.
People who have normal vision, either naturally or with glasses or contact lenses.
People who have normal hearing and are able to speak and express themselves verbally.
People who are able to attend regular medical or psychological check-ins throughout the study period.

Who may not be able to join:

People who have been diagnosed with other significant neurological or mental health conditions besides GAD.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +886911164386

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05921773

Sponsor: National Taiwan University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

Trial contact: +886911164386

More information: https://clinicaltrials.gov/study/NCT05921773

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with Generalized Anxiety Disorder (GAD) by a psychiatrist using standard diagnostic guidelines (DSM-V).
People whose first language is Chinese.
People who are right-handed.
People who have normal vision, either naturally or with glasses or contact lenses.
People who have normal hearing and are able to speak and express themselves verbally.
People who are able to attend regular medical or psychological check-ins throughout the study period.

Who may not be able to join:

People who have been diagnosed with other significant neurological or mental health conditions besides GAD.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Taiwan University Hospital

Registry

ClinicalTrials.gov

Start date

1 May 2023

Est. completion

30 April 2027

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Change in cerebral hemodynamics from functional near-infrared spectroscopy (fNIRS); Change in severity of physiological and psychological anxious symptoms as assessed by Hamilton Anxiety Rating Scale (HARS); Change in temporary and long-term anxiety levels as assessed by State-Trait Anxiety Inventory (STAI); Change in anxiety level as reported in Visual Analog Scale (VAS); Change in physiological anxious symptoms indicated by Heart Rate Variability (HRV)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov